162 related articles for article (PubMed ID: 29027251)
1. New Biguanides as Anti-Diabetic Agents, Part II: Synthesis and Anti-Diabetic Properties Evaluation of 1-Arylamidebiguanide Derivatives as Agents of Insulin Resistant Type II Diabetes.
Basyouni WM; Abbas SY; El Shehry MF; El-Bayouki KAM; Aly HF; Arafa A; Soliman MS
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027251
[TBL] [Abstract][Full Text] [Related]
2. New Biguanides as Anti-Diabetic Agents Part I: Synthesis and Evaluation of 1-Substituted Biguanide Derivatives as Anti-Diabetic Agents of Type II Diabetes Insulin Resistant.
Abbas SY; Basyouni WM; El-Bayouk KAM; Tohamy WM; Aly HF; Arafa A; Soliman MS
Drug Res (Stuttg); 2017 Oct; 67(10):557-563. PubMed ID: 28651259
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 1-Substituted-Biguanide Derivatives as Anti-Diabetic Agents for Type II Diabetes Insulin Resistant.
Abbas SY; Basyouni WM; El-Bayouki KA; Abdel-Rahman RF
Drug Res (Stuttg); 2016 Jul; 66(7):377-83. PubMed ID: 27191826
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and hyperglycemic, biochemical and histopathological evaluation of novel sulfonylbiguanide and sulfonylurea derivatives as potent anti-diabetic agents.
Basyouni WM; Abbas SY; El-Bayouki KAM; Younis EA; Ali SA; Aly HF
Bioorg Chem; 2021 Dec; 117():105418. PubMed ID: 34736133
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
[TBL] [Abstract][Full Text] [Related]
6. [Structure and mechanisms of action of biguanides].
Fujimoto S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():377-81. PubMed ID: 12387021
[No Abstract] [Full Text] [Related]
7. Vanadyl-biguanide complexes as potential synergistic insulin mimics.
Woo LC; Yuen VG; Thompson KH; McNeill JH; Orvig C
J Inorg Biochem; 1999 Sep; 76(3-4):251-7. PubMed ID: 10605840
[TBL] [Abstract][Full Text] [Related]
8. The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocin induced diabetes.
Kanigür-Sultuybek G; Güven M; Onaran I; Tezcan V; Cenani A; Hatemi H
J Basic Clin Physiol Pharmacol; 1995; 6(3-4):271-80. PubMed ID: 8852272
[TBL] [Abstract][Full Text] [Related]
9. Improving management of type 2 diabetes mellitus: 2. Biguanides.
Quillen DM; Samraj G; Kuritzky L
Hosp Pract (1995); 1999 Oct; 34(11):41-4. PubMed ID: 10887428
[No Abstract] [Full Text] [Related]
10. Biguanides: Species with versatile therapeutic applications.
Kathuria D; Raul AD; Wanjari P; Bharatam PV
Eur J Med Chem; 2021 Jul; 219():113378. PubMed ID: 33857729
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative Effect of Adjunct Therapy of Metformin with Atorvastatin on Streptozotocin-induced Diabetes Mellitus in Rats.
Singh BK; Singh A; Kumar V
Drug Res (Stuttg); 2016 Jan; 66(1):28-32. PubMed ID: 25853448
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic activities of Acanthopanax senticosus polysaccharide (ASP) in combination with metformin.
Fu J; Fu J; Yuan J; Zhang N; Gao B; Fu G; Tu Y; Zhang Y
Int J Biol Macromol; 2012 Apr; 50(3):619-23. PubMed ID: 22326821
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
Ashokkumar N; Pari L; Manimekalai A; Selvaraju K
J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992
[TBL] [Abstract][Full Text] [Related]
14. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
Waisundara VY; Hsu A; Huang D; Tan BK
Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats.
Asgary S; Rafieian-Kopaei M; Shamsi F; Najafi S; Sahebkar A
J Complement Integr Med; 2014 Jun; 11(2):63-9. PubMed ID: 24710636
[TBL] [Abstract][Full Text] [Related]
16. Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.
Mori K; Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Komori T; Nakashima E; Naruse K; Takeuchi N; Hotta N
Can J Physiol Pharmacol; 1997 Mar; 75(3):179-84. PubMed ID: 9164699
[TBL] [Abstract][Full Text] [Related]
17. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
18. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
19. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
